Sort   by:  
 Page size 
UnknownProtein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
Not available
S-EPMC5724081 | biostudies-literature
UnknownThe unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial.
Not available
S-EPMC8557337 | biostudies-literature
UnknownErythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.
Not available
S-EPMC4515982 | biostudies-literature
UnknownMechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.
Not available
S-EPMC11605688 | biostudies-literature
UnknownA genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.
Not available
S-EPMC3959809 | biostudies-literature
UnknownWithdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey.
Not available
S-EPMC10641048 | biostudies-literature
UnknownEffect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
Not available
S-EPMC10092300 | biostudies-literature
UnknownCommon and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Not available
S-EPMC8648564 | biostudies-literature
UnknownGenome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Not available
S-EPMC5867896 | biostudies-literature
UnknownAnalysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy.
Not available
S-EPMC7818383 | biostudies-literature
Sort   by:  
 Page size